# Therapeutic Confirmatory Study to Evaluate the Efficacy and Safety of Avanafil

> **NCT00903981** · PHASE3 · COMPLETED · sponsor: **JW Pharmaceutical** · enrollment: 208 (actual)

## Conditions studied

- Erectile Dysfunction

## Interventions

- **DRUG:** Avanafil
- **DRUG:** Avanafil
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT00903981
- **Lead sponsor:** JW Pharmaceutical
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2009-03
- **Primary completion:** 2009-10
- **Final completion:** 2009-11
- **Target enrollment:** 208 (ACTUAL)
- **Last updated:** 2010-04-23


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00903981

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00903981, "Therapeutic Confirmatory Study to Evaluate the Efficacy and Safety of Avanafil". Retrieved via AI Analytics 2026-08-18 from https://api.ai-analytics.org/clinical/NCT00903981. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*